Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

Ioannis Kardamatis (1852-1942): Pioneer of the Anti-Malaria Battle in Greece.

Michaleas SN, Sergentanis TN, Tsoucalas G, Vladimiros L, Diamantis A, Tentolouris N, Papaioannou T.

Infez Med. 2020 Mar 1;28(1):104-107.

2.

The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial.

Billings LK, Agner BFR, Altuntas Y, Grøn R, Halladin N, Klonoff DC, Tentolouris N, Jódar E.

J Diabetes Sci Technol. 2020 Feb 28:1932296820906888. doi: 10.1177/1932296820906888. [Epub ahead of print]

PMID:
32107930
3.

Association of Circulating Osteopontin Levels With Lower Extremity Arterial Disease in Subjects With Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study.

Eleftheriadou I, Tsilingiris D, Tentolouris A, Mourouzis I, Grigoropoulou P, Kapelios C, Pantos C, Makrilakis K, Tentolouris N.

Int J Low Extrem Wounds. 2020 Feb 11:1534734619898097. doi: 10.1177/1534734619898097. [Epub ahead of print]

PMID:
32041444
4.

Metabolic regulation of activins in healthy individuals and in obese patients undergoing bariatric surgery.

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Tsilingiris D, Alexandrou A, Mantzoros CS.

Diabetes Metab Res Rev. 2020 Feb 5:e3297. doi: 10.1002/dmrr.3297. [Epub ahead of print]

PMID:
32026536
5.

Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry.

Souliotis K, Koutsovasilis A, Vatheia G, Golna C, Nikolaidi S, Hatziagelaki E, Kotsa K, Koufakis T, Melidonis A, Papazafiropoulou A, Tentolouris N, Siami E, Sotiropoulos A.

BMC Endocr Disord. 2020 Jan 28;20(1):16. doi: 10.1186/s12902-020-0496-7.

6.

Endothelial progenitor cells and peripheral neuropathy in subjects with type 2 diabetes mellitus.

Eleftheriadou I, Dimitrakopoulou N, Kafasi N, Tentolouris A, Dimitrakopoulou A, Anastasiou IA, Mourouzis I, Jude E, Tentolouris N.

J Diabetes Complications. 2020 Apr;34(4):107517. doi: 10.1016/j.jdiacomp.2019.107517. Epub 2020 Jan 7.

PMID:
31928893
7.

A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe.

Fadini GP, Tentolouris N, Caballero Mateos I, Bellido Castañeda V, Morales Portillo C.

Diabetes Ther. 2020 Feb;11(2):423-436. doi: 10.1007/s13300-019-00744-6. Epub 2019 Dec 20.

8.

Carbohydrate restriction in the morning increases weight loss effect of a hypocaloric Mediterranean type diet: a randomized, parallel group dietary intervention in overweight and obese subjects.

Dellis D, Tsilingiris D, Eleftheriadou I, Tentolouris A, Sfikakis PP Jr, Dellis G, Karanasiou M, Meimari A, Dimosthenopoulos C, Lazarou S, Tentolouris N.

Nutrition. 2020 Mar;71:110578. doi: 10.1016/j.nut.2019.110578. Epub 2019 Sep 5.

PMID:
31838462
9.

Improvement of metabolic control after 3-month use of real-time continuous glucose monitoring in patients with type 1 diabetes: a multicenter study in Greece.

Eleftheriadou I, Didangelos T, Pappas AC, Anastasiou E, Vasilopoulos C, Zoupas C, Manes C, Tsatsoulis A, Benroubi M, Pangalos E, Thomakos P, Gerasimidi-Vazeou A, Tentolouris N.

Hormones (Athens). 2019 Dec;18(4):443-450. doi: 10.1007/s42000-019-00153-1. Epub 2019 Nov 13.

PMID:
31721132
10.

Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials.

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Pilitsi E, Upadhyay J, Alexandrou A, Mantzoros CS.

Metabolism. 2019 Dec;101:153997. doi: 10.1016/j.metabol.2019.153997. Epub 2019 Oct 28.

PMID:
31672446
11.

The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update.

Arkoumani M, Papadopoulou-Marketou N, Nicolaides NC, Kanaka-Gantenbein C, Tentolouris N, Papassotiriou I.

Crit Rev Clin Lab Sci. 2020 Mar;57(2):114-125. doi: 10.1080/10408363.2019.1678565. Epub 2019 Oct 30.

PMID:
31663791
12.

Daily consumption of fruit-flavored yoghurt enriched with vitamins B contributes to lower energy intake and body weight reduction, in type 2 diabetic patients: a randomized clinical trial.

Yanni AE, Kokkinos A, Psychogiou G, Binou P, Kartsioti K, Chatzigeorgiou A, Konstantopoulos P, Perrea D, Tentolouris N, Karathanos VT.

Food Funct. 2019 Nov 1;10(11):7435-7443. doi: 10.1039/c9fo01796h. Epub 2019 Oct 30.

PMID:
31663569
13.

Ointments containing Ceratothoa oestroides extract: Evaluation of their healing potential in the treatment of diabetic foot ulcers.

Meimeti E, Tentolouris N, Manes C, Loupa C, Provatopoulou X, Mostratos D, Vitsos A, Roussis V, Tzouvelekis L, Miriagou V, Rallis M.

Wound Repair Regen. 2020 Mar;28(2):234-241. doi: 10.1111/wrr.12771. Epub 2019 Nov 27.

PMID:
31618498
14.

The role of amputative and non-amputative foot deformities severity in the risk for diabetic ulceration classification systems building: a cross-sectional and case-control pilot investigation.

Kossioris A, Tentolouris N, Loupa CV, Tyllianakis M.

Pan Afr Med J. 2019 Jun 11;33:103. doi: 10.11604/pamj.2019.33.103.17684. eCollection 2019.

15.

SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects.

Tentolouris A, Vlachakis P, Tzeravini E, Eleftheriadou I, Tentolouris N.

Int J Environ Res Public Health. 2019 Aug 17;16(16). pii: E2965. doi: 10.3390/ijerph16162965. Review.

16.

Pythagorean self-awareness intervention: A novel cognitive stress management technique for body weight control.

Simos DS, Kokkinos A, Tentolouris N, Dimosthenopoulos C, Mantzou E, Artemiadis A, Bacopoulou F, Nicolaides NC, Kosta O, Chrousos GP, Darviri C.

Eur J Clin Invest. 2019 Oct;49(10):e13164. doi: 10.1111/eci.13164. Epub 2019 Sep 16.

PMID:
31421060
17.

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement.

Kolovou GD, Watts GF, Mikhailidis DP, Pérez-Martínez P, Mora S, Bilianou H, Panotopoulos G, Katsiki N, Ooi TC, Lopez-Miranda J, Tybjærg-Hansen A, Tentolouris N, Nordestgaard BG.

Curr Vasc Pharmacol. 2019;17(5):538-540. doi: 10.2174/1570161117999190517115432.

PMID:
31418346
18.

Marine Isopod Ceratothoa Oestroides Extract: a Novel Treatment for Diabetic Foot Ulcers? Case Report of an Immunosuppressed Patient.

Meimeti E, Tentolouris N, Loupa C, Roussis V, Rallis M.

Med Arch. 2019 Apr;73(2):131-133. doi: 10.5455/medarh.2019.73.131-133.

19.

IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy.

Miller E, Doshi A, Grøn R, Jódar E, Őrsy P, Ranthe MF, Sugimoto D, Tentolouris N, Viljoen A, Billings LK.

Diabetes Obes Metab. 2019 Dec;21(12):2643-2650. doi: 10.1111/dom.13851. Epub 2019 Aug 28.

20.

Quality of life in subjects with type 2 diabetes mellitus with diabetic retinopathy: A case-control study.

Ligda G, Ploubidis D, Foteli S, Kontou PI, Nikolaou C, Tentolouris N.

Diabetes Metab Syndr. 2019 Mar - Apr;13(2):947-952. doi: 10.1016/j.dsx.2018.12.012. Epub 2018 Dec 20.

PMID:
31336549
21.

Management of diabetes mellitus and patients' attitude towards the disease: Data from a nationwide study in Greece.

Tentolouris A, Eleftheriadou I, Tzeravini E, Athanasakis K, Anastasiou IA, Kyriopoulos J, Tentolouris N.

Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1159-1164. doi: 10.1016/j.dsx.2019.01.030. Epub 2019 Jan 26.

PMID:
31336459
22.

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review.

Kolovou GD, Watts GF, Mikhailidis DP, Pérez-Martínez P, Mora S, Bilianou H, Panotopoulos G, Katsiki N, Ooi TC, Lopez-Miranda J, Tybjærg-Hansen A, Tentolouris N, Nordestgaard BG.

Curr Vasc Pharmacol. 2019;17(5):515-537. doi: 10.2174/1570161117666190503123911.

PMID:
31309820
23.

Efficacy of a Ceratothoa oestroides Olive Oil Extract in Patients With Chronic Ulcers: A Pilot Study.

Vitsos A, Tsagarousianos C, Vergos O, Stithos D, Mathioudakis D, Vitsos I, Zouni P, Kakolyri A, Meimeti E, Kyriazi M, Antoniadou I, Tentolouris N, Dallas P, Roussis V, Rallis M.

Int J Low Extrem Wounds. 2019 Sep;18(3):309-316. doi: 10.1177/1534734619856143. Epub 2019 Jun 25.

PMID:
31237193
24.

Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes.

Doupis J, Alexandrides T, Elisaf M, Melidonis A, Bousboulas S, Thanopoulou A, Pagkalos EM, Avramidis I, Pappas A, Arvaniti E, Karamousouli E, Voss B, Tentolouris N.

Diabetes Ther. 2019 Aug;10(4):1407-1422. doi: 10.1007/s13300-019-0648-9. Epub 2019 Jun 20.

25.

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text.

Kolovou GD, Watts GF, Mikhailidis DP, Pérez-Martínez P, Mora S, Bilianou H, Panotopoulos G, Katsiki N, Ooi TC, Lopez-Miranda J, Tybjærg-Hansen A, Tentolouris N, Nordestgaard BG.

Curr Vasc Pharmacol. 2019;17(5):498-514. doi: 10.2174/1570161117666190507110519.

PMID:
31060488
26.

Clinical benefits of switching to insulin degludec irrespective of previous basal insulin therapy in people with Type 1 or Type 2 diabetes: evidence from a European, multicentre, retrospective, non-interventional study (EU-TREAT).

Knudsen ST, Lapolla A, Schultes B, Tentolouris N, Catarig AM, Wolden ML, Siegmund T.

Diabet Med. 2019 Jul;36(7):868-877. doi: 10.1111/dme.13976. Epub 2019 May 2.

27.

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence.

Katsiki N, Dimitriadis G, Hahalis G, Papanas N, Tentolouris N, Triposkiadis F, Tsimihodimos V, Tsioufis C, Mikhailidis DP, Mantzoros C.

Metabolism. 2019 Jul;96:92-100. doi: 10.1016/j.metabol.2019.04.008. Epub 2019 Apr 11. Review.

PMID:
30980838
28.

Advancing pharmacotherapy for diabetic foot ulcers.

Eleftheriadou I, Tentolouris A, Tentolouris N, Papanas N.

Expert Opin Pharmacother. 2019 Jun;20(9):1153-1160. doi: 10.1080/14656566.2019.1598378. Epub 2019 Apr 8. Review.

PMID:
30958725
29.

Switching "Real-World" Diabetes Patients to Degludec from Other Basal Insulins Provides Different Clinical Benefits According to Their Baseline Glycemic Control.

Tentolouris N, Knudsen ST, Lapolla A, Wolden ML, Haldrup S, Schultes B.

Adv Ther. 2019 May;36(5):1201-1210. doi: 10.1007/s12325-019-00916-7. Epub 2019 Mar 16.

30.

Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin.

Vilsbøll T, Blevins TC, Jodar E, Poulter N, Tentolouris N, Ross Agner BF, Lehmann L, Leiter LA.

Diabetes Obes Metab. 2019 Jun;21(6):1506-1512. doi: 10.1111/dom.13675. Epub 2019 Apr 8.

31.

Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice.

Tentolouris A, Eleftheriadou I, Tzeravini E, Tsilingiris D, Paschou SA, Siasos G, Tentolouris N.

Curr Med Chem. 2020;27(7):1089-1131. doi: 10.2174/0929867326666190119154152.

PMID:
30663560
32.

A clinical score for prediction of elevated aortic stiffness: derivation and validation in 3943 hypertensive patients.

Xaplanteris P, Vlachopoulos C, Protogerou AD, Aznaouridis K, Terentes-Printzios D, Argyris AA, Tentolouris N, Sfikakis PP, Tousoulis D.

J Hypertens. 2019 Feb;37(2):339-346. doi: 10.1097/HJH.0000000000001904.

PMID:
30645208
33.

Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis.

Batzias K, Antonopoulos AS, Oikonomou E, Siasos G, Bletsa E, Stampouloglou PK, Mistakidi CV, Noutsou M, Katsiki N, Karopoulos P, Charalambous G, Thanopoulou A, Tentolouris N, Tousoulis D.

J Diabetes Res. 2018 Dec 4;2018:1232583. doi: 10.1155/2018/1232583. eCollection 2018.

34.

S100B Levels in Patients with Type 2 Diabetes Mellitus and Co-Occurring Depressive Symptoms.

Katsanou P, Tentolouris N, Perrea D, Katsanos S, Ntova V, Antrian V, Konstantopoulos P, Politis A.

Depress Res Treat. 2018 Nov 18;2018:5304759. doi: 10.1155/2018/5304759. eCollection 2018.

35.

Low prevalence of rheumatoid arthritis among patients with pre-existing type 2 diabetes mellitus.

Tentolouris A, Thanopoulou A, Tentolouris N, Eleftheriadou I, Voulgari C, Andrianakos A, Sfikakis PP.

Ann Transl Med. 2018 Oct;6(20):399. doi: 10.21037/atm.2018.09.14.

36.

Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia.

Hackinger S, Prins B, Mamakou V, Zengini E, Marouli E, Brčić L, Serafetinidis I, Lamnissou K, Kontaxakis V, Dedoussis G, Gonidakis F, Thanopoulou A, Tentolouris N, Tsezou A, Zeggini E.

Transl Psychiatry. 2018 Nov 23;8(1):252. doi: 10.1038/s41398-018-0304-6.

37.

The association of diabetic microvascular and macrovascular disease with cutaneous circulation in patients with type 2 diabetes mellitus.

Eleftheriadou I, Tentolouris A, Grigoropoulou P, Tsilingiris D, Anastasiou I, Kokkinos A, Perrea D, Katsilambros N, Tentolouris N.

J Diabetes Complications. 2019 Feb;33(2):165-170. doi: 10.1016/j.jdiacomp.2018.10.008. Epub 2018 Oct 12.

PMID:
30446479
38.

Follistatins in glucose regulation in healthy and obese individuals.

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Tsilingiris D, Alexandrou A, Mantzoros CS.

Diabetes Obes Metab. 2019 Mar;21(3):683-690. doi: 10.1111/dom.13572. Epub 2018 Dec 3.

39.

Advancements in improving health-related quality of life in patients living with diabetic foot ulcers.

Tzeravini E, Tentolouris A, Tentolouris N, Jude EB.

Expert Rev Endocrinol Metab. 2018 Nov;13(6):307-316. doi: 10.1080/17446651.2018.1541403. Epub 2018 Nov 1. Review.

PMID:
30381974
40.

Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia.

Grigoropoulou P, Tentolouris A, Eleftheriadou I, Tsilingiris D, Vlachopoulos C, Sykara M, Tentolouris N.

Diab Vasc Dis Res. 2019 Jan;16(1):38-46. doi: 10.1177/1479164118805320. Epub 2018 Oct 17.

PMID:
30328360
41.

Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis.

Karageorgiou V, Papaioannou TG, Bellos I, Alexandraki K, Tentolouris N, Stefanadis C, Chrousos GP, Tousoulis D.

Metabolism. 2019 Jan;90:20-30. doi: 10.1016/j.metabol.2018.10.002. Epub 2018 Oct 12.

PMID:
30321535
42.

Pain management of chronic wounds: Diabetic ulcers and beyond.

Paschou SA, Stamou M, Vuagnat H, Tentolouris N, Jude E.

Maturitas. 2018 Nov;117:17-21. doi: 10.1016/j.maturitas.2018.08.013. Epub 2018 Sep 5. Review.

PMID:
30314556
43.

Plasma Irisin Levels in Subjects with Type 1 Diabetes: Comparison with Healthy Controls.

Tentolouris A, Eleftheriadou I, Tsilingiris D, Anastasiou IA, Kosta OA, Mourouzis I, Kokkinos A, Pantos C, Katsilambros N, Tentolouris N.

Horm Metab Res. 2018 Nov;50(11):803-810. doi: 10.1055/a-0748-6170. Epub 2018 Oct 4.

PMID:
30286484
44.

Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.

Liakos A, Lambadiari V, Bargiota A, Kitsios K, Avramidis I, Kotsa K, Gerou S, Boura P, Tentolouris N, Dimitriadis G, Tsapas A.

Diabetes Obes Metab. 2019 Mar;21(3):517-524. doi: 10.1111/dom.13541. Epub 2018 Oct 23.

PMID:
30242948
45.

Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis.

Liaskos C, Koliaki C, Alexiadou K, Argyrakopoulou G, Tentolouris N, Diamantis T, Alexandrou A, Katsilambros N, Kokkinos A.

Obes Surg. 2018 Dec;28(12):3997-4005. doi: 10.1007/s11695-018-3454-y.

PMID:
30112599
46.

Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.

Mamakou V, Hackinger S, Zengini E, Tsompanaki E, Marouli E, Serafetinidis I, Prins B, Karabela A, Glezou E, Southam L, Rayner NW, Kuchenbaecker K, Lamnissou K, Kontaxakis V, Dedoussis G, Gonidakis F, Thanopoulou A, Tentolouris N, Zeggini E.

BMC Psychiatry. 2018 Aug 2;18(1):249. doi: 10.1186/s12888-018-1826-4.

47.

Diabetic Foot Infections: Update on Management.

Nikoloudi M, Eleftheriadou I, Tentolouris A, Kosta OA, Tentolouris N.

Curr Infect Dis Rep. 2018 Aug 1;20(10):40. doi: 10.1007/s11908-018-0645-6. Review.

PMID:
30069605
48.

The Effect of the Oral Administration of Leucine on Endothelial Function, Glucose and Insulin Concentrations in Healthy Subjects.

Argyrakopoulou G, Kontrafouri P, Eleftheriadou I, Kokkinos A, Arapostathi C, Kyriaki D, Perrea D, Revenas C, Katsilambros N, Tentolouris N.

Exp Clin Endocrinol Diabetes. 2019 Sep;127(8):505-510. doi: 10.1055/a-0597-8985. Epub 2018 Jun 11.

PMID:
29890542
49.

Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus.

Eleftheriadou I, Drosos GC, Tentolouris A, Konstantonis G, Sfikakis PP, Protogerou AD, Tentolouris N.

J Hum Hypertens. 2018 Sep;32(8-9):531-539. doi: 10.1038/s41371-018-0070-1. Epub 2018 May 23.

PMID:
29789692
50.

Schizophrenia and type 2 diabetes mellitus.

Mamakou V, Thanopoulou A, Gonidakis F, Tentolouris N, Kontaxakis V.

Psychiatriki. 2018 Jan-Mar;29(1):64-73. doi: 10.22365/jpsych.2018.291.64. Review.

Supplemental Content

Loading ...
Support Center